12:00 AM
 | 
May 19, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Ferrer, Medivir sales and marketing update

Medivir launched Adasuve loxapine in Sweden, Norway, Finland and Denmark to treat mild to moderate agitation in adults with schizophrenia or bipolar disorder. Medivir has exclusive, Nordic commercialization rights to Adasuve from Ferrer...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >